|
WBP11 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.66533453693773E-15 |
| Normal-vs-Stage2 |
7.8600999997569E-07 |
| Normal-vs-Stage3 |
1.4361845046551E-12 |
| Normal-vs-Stage4 |
9.52105061458042E-12 |
| Stage1-vs-Stage2 |
4.599600E-01 |
| Stage1-vs-Stage3 |
4.974600E-01 |
| Stage1-vs-Stage4 |
4.261800E-01 |
| Stage2-vs-Stage3 |
3.022000E-01 |
| Stage2-vs-Stage4 |
2.574800E-01 |
| Stage3-vs-Stage4 |
8.035000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.22044604925031E-15 |
| Normal-vs-AfricanAmerican |
4.836900E-04 |
| Normal-vs-Asian |
6.93390000972016E-09 |
| Caucasian-vs-AfricanAmerican |
1.420620E-01 |
| Caucasian-vs-Asian |
8.413400E-01 |
| AfricanAmerican-vs-Asian |
2.606000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.81805698168591E-13 |
| Normal-vs-Female |
1.62547753035369E-12 |
| Male-vs-Female |
5.568600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.07345252078994E-12 |
| Normal-vs-Age(41-60Yrs) |
3.35065308831872E-13 |
| Normal-vs-Age(61-80Yrs) |
2.67019739652596E-12 |
| Normal-vs-Age(81-100Yrs) |
3.363700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.751400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.367200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.688400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.557600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.806600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.586600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.717800E-01 |
| Classical-VS-Follicular |
5.019000E-04 |
| Classical-VS-Other |
1.670990E-01 |
| Classical-VS-Normal |
1.94499971684081E-12 |
| Tall-VS-Follicular |
1.363160E-01 |
| Tall-VS-Other |
2.741000E-01 |
| Tall-VS-Normal |
2.0146000001553E-07 |
| Follicular-VS-Other |
8.690200E-01 |
| Follicular-VS-Normal |
1.70941039101535E-12 |
| Other-VS-Normal |
2.200600E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.8159700933611E-14 |
| Normal-vs-N1 |
9.81803527366765E-12 |
| N0-vs-N1 |
1.353360E-01 |
|
|
